<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02889341</url>
  </required_header>
  <id_info>
    <org_study_id>1303-SEV-00-CG</org_study_id>
    <nct_id>NCT02889341</nct_id>
  </id_info>
  <brief_title>Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility</brief_title>
  <acronym>DHA</acronym>
  <official_title>Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Sevilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Sevilla</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sperm parameters will be examined before DHA (DHA=Docosahexanoic Acid) consumption, after one
      months and after 2 months taken Docosahexanoic Acid or placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, randomized, double blind, placebo-controlled intervention study within
      individuals. Assisted reproduction unit and academic research laboratory. One hundred an
      eighty human semen samples from 60 infertile patients of IVI Sevilla clinic were finally
      included. Assessment of oxidative stress, apoptosis, lipid peroxidation, mitochondrial
      membrane potential, DNA fragmentation and standard sperm parameters before and after
      supplementation with different DHA doses (0.5, 1 and 2 g) or placebo for 1 and 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 22, 2013</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">May 26, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sperm cell concentration</measure>
    <time_frame>Three months</time_frame>
    <description>Measured in millions of sperm cells per ml of semen sample</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sperm cell motility</measure>
    <time_frame>Three months</time_frame>
    <description>Measured in percentage of each type of motile sperm according to OMS 2010 criteria (A-D).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sperm cell morphology</measure>
    <time_frame>Three</time_frame>
    <description>Measured in percentage of sperm cell with normal morphology according to OMS 2010 criteria.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Male Infertility</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>500 mg DHA/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>500 mg DHA/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1g DHA/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1g DHA/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2g DHA/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2g DHA/day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA</intervention_name>
    <arm_group_label>500 mg DHA/day</arm_group_label>
    <arm_group_label>1g DHA/day</arm_group_label>
    <arm_group_label>2g DHA/day</arm_group_label>
    <other_name>Docosahexaenoic acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  1 year of infertility

          -  &gt; 10 mill/ml of sperms

          -  Motility &lt; 60% progressive

          -  Morphology &lt; 2% (WHO 2010)

        Exclusion criteria:

        No meeting the inclusion criteria.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2016</study_first_submitted>
  <study_first_submitted_qc>September 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2016</study_first_posted>
  <last_update_submitted>August 1, 2017</last_update_submitted>
  <last_update_submitted_qc>August 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Docosahexanoic Acid,</keyword>
  <keyword>DNA fragmentation</keyword>
  <keyword>male fertility</keyword>
  <keyword>Sperm parameters improvements</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

